title: Biodegradable cross-linked starch/protein microcapsules containing proteinase inhibitor for oral protein administration.
abstract: The objective of this study is to demonstrate the feasibility of microcapsules containing a protein and a proteinase inhibitor in order to allow the oral administration of proteic or peptidic drug. Starch/bovine serum albumin mixed-walled microcapsules were prepared using interfacial cross-linking with terephthaloyl chloride. The microcapsules were loaded with native or amino-protected aprotinin by incorporating protease inhibitors in the aqueous phase during the cross-linking process. Microcapsules can be degraded in the presence of alpha-amylase. The influence of the formulation parameters on the in vitro release of the inhibitor activity and the protein was studied. The protective effect of microcapsules with aprotinin for bovine serum albumin was revealed in vitro. The presence of the native bovine serum albumin was demonstrated after incubation of the microcapsules with aprotinin in a mixture of alpha-amylase (5.4 U/ml) and trypsin (900 spectrophotometric BAEE units/ml) for 3 h at 37 degrees C, whereas the protein was completely degraded in the release medium of the microcapsules without aprotinin.
authors.affiliation: Faculty of Chemistry, Lomonosov Moscow State University, 119899, Moscow, Russia.
authors.forename: N V
authors.initials: NV
authors.lastname: Larionova
authors.forename: G
authors.initials: G
authors.lastname: Ponchel
authors.forename: D
authors.initials: D
authors.lastname: Duchêne
authors.forename: N I
authors.initials: NI
authors.lastname: Larionova
mesh_terms: D000284:Administration, Oral; D000818:Animals; D007611:Aprotinin / Q000737:chemistry / Q000493:pharmacokinetics; D001673:Biodegradation, Environmental; D002021:Buffers; D002214:Capsules / Q000737:chemistry*; D002417:Cattle; D002851:Chromatography, High Pressure Liquid; D003432:Cross-Linking Reagents; D003692:Delayed-Action Preparations; D004339:Drug Compounding; D016503:Drug Delivery Systems; D006863:Hydrogen-Ion Concentration; D019563:Mechanics; D008855:Microscopy, Electron, Scanning; D010316:Particle Size; D010795:Phthalic Acids / Q000494:pharmacology; D011480:Protease Inhibitors / Q000378:metabolism / Q000493:pharmacokinetics*; D011506:Proteins / Q000737:chemistry*; D012710:Serum Albumin, Bovine / Q000737:chemistry / Q000493:pharmacokinetics; D013213:Starch / Q000737:chemistry*; D013997:Time Factors; D014357:Trypsin / Q000378:metabolism
chemical_list: D002021:Buffers; D002214:Capsules; D003432:Cross-Linking Reagents; D003692:Delayed-Action Preparations; D010795:Phthalic Acids; D011480:Protease Inhibitors; D011506:Proteins; D012710:Serum Albumin, Bovine; D013213:Starch; D007611:Aprotinin; D014357:Trypsin; C059743:terephthaloyl chloride